全文获取类型
收费全文 | 1208篇 |
免费 | 89篇 |
国内免费 | 7篇 |
出版年
2023年 | 7篇 |
2022年 | 24篇 |
2021年 | 39篇 |
2020年 | 16篇 |
2019年 | 32篇 |
2018年 | 51篇 |
2017年 | 24篇 |
2016年 | 38篇 |
2015年 | 58篇 |
2014年 | 69篇 |
2013年 | 90篇 |
2012年 | 106篇 |
2011年 | 96篇 |
2010年 | 60篇 |
2009年 | 55篇 |
2008年 | 62篇 |
2007年 | 58篇 |
2006年 | 41篇 |
2005年 | 58篇 |
2004年 | 46篇 |
2003年 | 49篇 |
2002年 | 33篇 |
2001年 | 14篇 |
2000年 | 11篇 |
1999年 | 15篇 |
1998年 | 13篇 |
1997年 | 19篇 |
1996年 | 4篇 |
1995年 | 13篇 |
1994年 | 11篇 |
1993年 | 11篇 |
1992年 | 7篇 |
1991年 | 7篇 |
1990年 | 2篇 |
1988年 | 5篇 |
1987年 | 9篇 |
1986年 | 3篇 |
1985年 | 8篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1969年 | 4篇 |
1968年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有1304条查询结果,搜索用时 15 毫秒
991.
Ji-Won Moon Claudia J. Rawn Adam J. Rondinone Lonnie J. Love Yul Roh S. Michelle Everett Robert J. Lauf Tommy J. Phelps 《Journal of industrial microbiology & biotechnology》2010,37(10):1023-1031
Production of both nano-sized particles of crystalline pure phase magnetite and magnetite substituted with Co, Ni, Cr, Mn,
Zn or the rare earths for some of the Fe has been demonstrated using microbial processes. This microbial production of magnetic
nanoparticles can be achieved in large quantities and at low cost. In these experiments, over 1 kg (wet weight) of Zn-substituted
magnetite (nominal composition of Zn0.6Fe2.4O4) was recovered from 30 l fermentations. Transmission electron microscopy (TEM) was used to confirm that the extracellular
magnetites exhibited good mono-dispersity. TEM results also showed a highly reproducible particle size and corroborated average
crystallite size (ACS) of 13.1 ± 0.8 nm determined through X-ray diffraction (N = 7) at a 99% confidence level. Based on scale-up experiments performed using a 35-l reactor, the increase in ACS reproducibility
may be attributed to a combination of factors including an increase of electron donor input, availability of divalent substitution
metal ions and fewer ferrous ions in the case of substituted magnetite, and increased reactor volume overcoming differences
in each batch. Commercial nanometer sized magnetite (25–50 nm) may cost $500/kg. However, microbial processes are potentially
capable of producing 5–90 nm pure or substituted magnetites at a fraction of the cost of traditional chemical synthesis. While
there are numerous approaches for the synthesis of nanoparticles, bacterial fermentation of magnetite or metal-substituted
magnetite may represent an advantageous manufacturing technology with respect to yield, reproducibility and scalable synthesis
with low costs at low energy input. 相似文献
992.
Nasser H. Goradel Nejad Mohammadi Hamed Haghi-Aminjan Bagher Farhood Babak Negahdari Amirhossein Sahebkar 《Journal of cellular physiology》2019,234(2):1099-1110
MicroRNAs (miRNAs, miRs) are small (21–25 nucleotides) endogenous and noncoding RNAs involved in many cellular processes such as apoptosis, development, proliferation, and differentiation via binding to the 3′-untranslated region of the target mRNA and inhibiting its translation. Angiogenesis is a hallmark of cancer, which provides oxygen and nutrition for tumor growth while removing deposits and wastes from the tumor microenvironment. There are many angiogenesis stimulators, among which vascular endothelial growth factor (VEGF) is the most well known. VEGF has three tyrosine kinase receptors, which, following VEGF binding, initiate proliferation, invasion, migration, and angiogenesis of endothelial cells in the tumor environment. One of the tumor microenvironment conditions that induce angiogenesis through increasing VEGF and its receptors expression is hypoxia. Several miRNAs have been identified that affect different targets in the tumor angiogenesis pathway. Most of these miRNAs affect VEGF and its tyrosine kinase receptors expression downstream of the hypoxia-inducible Factor 1 (HIF-1). This review focuses on tumor angiogenesis regulation by miRNAs and the mechanism underlying this regulation. 相似文献
993.
Masoud Najafi Nasser Hashemi Goradel Bagher Farhood Eniseh Salehi Maryam Shabani Nashtaei Neda Khanlarkhani Zahra Khezri Jamal Majidpoor Morteza Abouzaripour Mohsen Habibi Iraj Ragerdi Kashani Keywan Mortezaee 《Journal of cellular biochemistry》2019,120(3):2756-2765
Macrophages are the most abundant cells within the tumor stroma displaying noticeable plasticity, which allows them to perform several functions within the tumor microenvironment. Tumor-associated macrophages commonly refer to an alternative M2 phenotype, exhibiting anti-inflammatory and pro-tumoral effects. M2 cells are highly versatile and multi-tasking cells that directly influence multiple steps in tumor development, including cancer cell survival, proliferation, stemness, and invasiveness along with angiogenesis and immunosuppression. M2 cells perform these functions through critical interactions with cells related to tumor progression, including Th2 cells, cancer-associated fibroblasts, cancer cells, regulatory T cells (Tregs), and myeloid-derived suppressor cells. M2 cells also have negative cross-talks with tumor suppressor cells, including cytotoxic T cells and natural killer cells. Programed death-1 (PD-1) is one of the key receptors expressed in M2 cells that, upon interaction with its ligand PD-L1, plays cardinal roles for induction of immune evasion in cancer cells. In addition, M2 cells can neutralize the effects of the pro-inflammatory and anti-tumor M1 phenotype. Classically activated M1 cells express high levels of major histocompatibility complex molecules, and the cells are strong killers of cancer cells. Therefore, orchestrating M2 reprogramming toward an M1 phenotype would offer a promising approach for reversing the fate of tumor and promoting cancer regression. Macrophage switching toward an anti-inflammatory M1 phenotype could be used as an adjuvant with other approaches, including radiotherapy and immune checkpoint blockades, such as anti-PD-L1/PD-1 strategies. 相似文献
994.
Siew Ping Yap Tommy Julianto Jia Woei Wong Kah Hay Yuen 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1999,735(2):621
A simple high-performance liquid chromatographic method using fluorescence detection was developed for the determination of vitamin E especially δ-, γ- and α-tocotrienols in human plasma. The method entailed direct injection of plasma sample after deproteinization using a 3:2 mixture of acetonitrile–tetrahydrofuran. The mobile phase comprised 0.5% (v/v) of distilled water in methanol. Analyses were run at a flow-rate of 1.5 ml/min with the detector operating at an excitation wavelength of 296 nm and emission wavelength of 330 nm. This method is specific and sensitive, with a quantification limit of approximately 40, 34 and 16 ng/ml for α-, γ- and δ-tocotrienol, respectively. The mean absolute recovery values were about 98% while the within-day and between-day relative standard deviation and percent error values of the assay method were all less than 12.0% for α-, γ- and δ-tocotrienol. The calibration curve was linear over a concentration range of 40–2500, 30–4000 and 16–1000 ng/ml for α-, γ- and δ-tocotrienol, respectively. Application of the method in a bioavailability study for determination of the above compounds was also demonstrated. 相似文献
995.
996.
Julia H. Goedecke Naomi S. Levitt Estelle V. Lambert Kristina M. Utzschneider Mirjam V. Faulenbach Joel A. Dave Sacha West Hendriena Victor Juliet Evans Tommy Olsson Brian R. Walker Jonathan R. Seckl Steven E. Kahn 《Obesity (Silver Spring, Md.)》2009,17(8):1506-1512
Black South African women are more insulin resistant than BMI‐matched white women. The objective of the study was to characterize the determinants of insulin sensitivity in black and white South African women matched for BMI. A total of 57 normal‐weight (BMI 18–25 kg/m2) and obese (BMI > 30 kg/m2) black and white premenopausal South African women underwent the following measurements: body composition (dual‐energy X‐ray absorptiometry), body fat distribution (computerized tomography (CT)), insulin sensitivity (SI, frequently sampled intravenous glucose tolerance test), dietary intake (food frequency questionnaire), physical activity (Global Physical Activity Questionnaire), and socioeconomic status (SES, demographic questionnaire). Black women were less insulin sensitive (4.4 ± 0.8 vs. 9.5 ± 0.8 and 3.0 ± 0.8 vs. 6.0 ± 0.8 × 10?5/min/(pmol/l), for normal‐weight and obese women, respectively, P < 0.001), but had less visceral adipose tissue (VAT) (P = 0.051), more abdominal superficial subcutaneous adipose tissue (SAT) (P = 0.003), lower SES (P < 0.001), and higher dietary fat intake (P = 0.001) than white women matched for BMI. SI correlated with deep and superficial SAT in both black (R = ?0.594, P = 0.002 and R = 0.495, P = 0.012) and white women (R = ?0.554, P = 0.005 and R = ?0.546, P = 0.004), but with VAT in white women only (R = ?0.534, P = 0.005). In conclusion, body fat distribution is differentially associated with insulin sensitivity in black and white women. Therefore, the different abdominal fat depots may have varying metabolic consequences in women of different ethnic origins. 相似文献
997.
998.
Mahdi D. Davari Homayoon Bahrami Mansour Zahedi Nasser Safari 《Journal of molecular modeling》2009,15(11):1299-1315
In order to obtain a better molecular understanding of inhibitory role of tin metal in the verdoheme ring opening process,
hydrolysis of three possibly six, five, and four coordinate verdoheme complexes of tin(IV) and (II) have been studied using
DFT method. The results of calculations indicate that, in excellent accord with experimental reports, hydrolysis of different
possibly coordinated tin(IV) and (II) verdohemes does not lead to the opening of the macrocycle. Contrary to iron and zinc
verdohemes, in five and four coordinate verdoheme complexes of tin(IV) and (II), formation of open ring helical complexes
of tin are unfavorable both thermodynamically and kinetically. In these pathways, coordination of hydroxide nucleophile to
tin metal due to the highly charged, exclusive oxophilicity nature of the Sn center, and high affinity of Sn to increase coordination
state are proposed responsible as inhibiting roles of tin via the ring opening. While, in saturated six coordinate tin(IV) and (II) verdoheme complexes the ring opening of tin verdohemes
is possible thermodynamically, but it is not predicted to occur from a kinetics point of view. In the six coordinate pathway,
tin plays no coordination role and direct addition of hydroxide nucleophile to the positive oxo-carbon centers and formation
of closed ring hydroxy compounds is proposed for preventing the verdoheme ring opening. These key points and findings have
been corroborated by the results obtained from atomic charge analysis, geometrical parameters, and molecular orbital calculations.
In addition, the results of inhibiting ring opening reaction of tin verdoheme complexes could support the great interest of
tin porphyrin analogues as pharmacologic means of chemoprevention of neonatal jaundice by the competitive inhibitory action
of tin porphyrins on heme oxygenase. 相似文献
999.
Nasser Said Mandour 《BioControl》2009,54(1):93-102
Toxicity of spinosad to immature stages of Chrysoperla carnea (Stephens) (Neuroptera: Chrysopidae) and its effect on the reproduction and survival of adult stages after direct spray and
ingestion treatments were evaluated. Spinosad was harmless to C. carnea eggs and pupae irrespective of concentrations or method of treatments. Direct spray of spinosad to first instar caused significant
reduction in rate of pupation and L1-adult survival, but did not affect the rate of adult emergence. Third-instar bioassay
revealed significant difference in L3-adult survival. When C. carnea first instars were fed upon spinosad-treated-Brevicoryne
brassicae (L.), significant differences in investigated parameters were not observed among different treatments. The weight of third
instar and pupae were comparable regardless of tested spinosad concentrations. Also, feeding on spinosad treated-B. brassicae had no negative impact on fecundity and fertility. Furthermore, ingestion of spinosad contaminated-B. brassicae significantly prolonged larval and larval + pupal periods. The larval feeding capacity of C. carnea did not differ significantly between larvae fed on spinosad-treated and untreated aphids with the exception of first instar.
When C. carnea adults were allowed to oviposit on spinosad treated-substrate, total number of eggs laid, percent of eggs laid on the treated
substrate and egg hatching did not differ from those of control. However, when adults were fed on spinosad-treated artificial
diet, negative effects on adult survival and fecundity were observed.
相似文献
Nasser Said MandourEmail: Email: |
1000.
Roudaina Nasser Mireia Pelegrin Henri-Alexandre Michaud Marc Plays Marc Piechaczyk Laurent Gros 《Journal of virology》2010,84(19):10169-10181
Using FrCasE retrovirus-infected newborn mice as a model system, we have shown recently that a long-lasting antiviral immune response essential for healthy survival emerges after a short treatment with a neutralizing (667) IgG2a isotype monoclonal antibody (MAb). This suggested that the mobilization of adaptive immunity by administered MAbs is key for the success in the long term for the MAb-based passive immunotherapy of chronic viral infections. We have addressed here whether the anti-FrCasE protective endogenous immunity is the mere consequence of viral propagation blunting, which would simply give time to the immune system to react, and/or to actual immunomodulation by the MAb during the treatment. To this aim, we have compared viral replication, disease progression, and antiviral immune responses between different groups of infected mice: (i) mice treated with either the 667 MAb, its F(ab′)2 fragment, or an IgM (672) with epitopic specificity similar to that of 667 but displaying different effector functions, and (ii) mice receiving no treatment but infected with a low viral inoculum reproducing the initial viral expansion observed in their infected/667 MAb-treated counterparts. Our data show that the reduction of FrCasE propagation is insufficient on its own to induce protective immunity and support a direct immunomodulatory action of the 667 MAb. Interestingly, they also point to sequential actions of the administered MAb. In a first step, viral propagation is exclusively controlled by 667 neutralizing activity, and in a second one, this action is complemented by FcγR-binding-dependent mechanisms, which most likely combine infected cell cytolysis and the modulation of the antiviral endogenous immune response. Such complementary effects of administered MAbs must be taken into consideration for the improvement of future antiviral MAb-based immunotherapies.Although monoclonal antibodies (MAbs) principally have been considered for anticancer applications heretofore (62, 64), they now are increasingly being considered to treat severe acute and chronic viral infections (43, 63, 83). The best-studied antiviral MAbs are (i) pavalizumab, a humanized anti-respiratory syncytial virus (RSV) MAb approved by the FDA in 1998 for treating severe lower-respiratory-tract diseases in infants (45); (ii) several anti-human immunodeficiency virus (HIV) MAbs, which have been used in macaque preclinical infection models and in several human trials (4, 5, 19, 27-30, 32, 42, 50, 55, 57, 76-79); and (iii) a few anti-hepatitis C virus (HCV) MAbs, some of which currently are being tested in humans (9, 22, 40). However, other MAbs, some of them of human origin, also have been generated against other human viruses in recent years. Among them are antibodies against Ebola virus (75), West Nile virus (WNV) (48, 53, 54), cytomegalovirus (CMV) (11), avian and human influenza viruses (59, 60, 73, 74), severe acute respiratory syndrome coronavirus (SARS CoV) (81), hepatitis B virus (HBV) (31, 35), Hanta virus (80, 82), and Nipah virus (80, 82). These antiviral MAbs all have been selected on the basis of their neutralizing activity and the possibility that they interfere with the antiviral immune response of treated hosts, because their effector functions have been considered surprisingly little so far. Addressing this question in clinical settings currently is not possible for a variety of reasons that include ethical, technical, and cost concerns. Therefore, we have turned to the neonatal infection of mice by the lethal FrCasE retrovirus as a model system. This model allowed us to show that a very short immunotherapy by a neutralizing MAb of the IgG2a isotype (667 MAb) can permit, in addition to an immediate direct effect on the viral load, the mounting of a long-lasting endogenous antiviral immunity, which is essential for viral control and healthy survival (23-25). Because of the broad therapeutic perspectives opened by this observation, it now is essential to elucidate the molecular and cellular mechanisms underlying this effect.FrCasE is a simple chimeric mouse retrovirus in which the env gene of the leukemogenic Friend murine leukemia virus (F-MuLV) was replaced by that of the neurodegeneration-inducing CasBr retrovirus (58). When 5 × 104 infectious particles are inoculated into newborn mice under the age of 5 to 6 days, FrCasE can enter the central nervous system (CNS) and induces a neurodegeneration fatal within 1 to 2 months with 100% incidence (15, 23, 41, 58). However, upon infection at a later time, FrCasE can no longer enter the CNS. Instead, it replicates only in the periphery and gives rise to a fatal erythroleukemia preceded by spleen enlargement and a dramatic drop of the hematocrit. Erythroleukemia incidence and incubation period, however, are variable, depending on the inoculum and the date of infection (46).667 is an IgG2a/κ (44) directed to the main viral receptor-binding site of CasBr Env (16). It displays both in vitro (44) and in vivo (56) neutralizing activities. When rapidly (<2 days) administered for a few days to neonatally FrCasE-infected pups, viral propagation is rapidly blunted, which prevents virus entry in the brain and subsequent neurodegeneration (23). Moreover, all 667-treated mice develop a strong, long-lasting antiviral immune response, which is necessary for them to survive healthy and with no sign of neurodegeneration or of erythroleukemia (23-25) and to resist viral challenges carried out as long as 14 months after first infection (23). Protective antiviral immunity is of a typical TH1 type with humoral and cytotoxic T-cell (CTL) contributions. The anti-FrCasE humoral contribution is high, sustained, and principally of the IgG2a type with both in vitro neutralization- and complement-dependent cytolysis activities (23). Interestingly, it shows typical secondary response characteristics in viral challenge experiments (23), and anti-FrCasE antibodies are transmitted transplacentally and through breastfeeding by mothers to children, where they manifest the same properties as those of 667 in the perinatal infection setting, i.e., they prevent mice from developing neurodegeneration and permit the induction of an endogenous protective antiviral immune response (25). Finally, the CTL response directed to infected cells was shown to be necessary for the protection of FrCasE-infected, 667-treated mice, as the depletion of CD8+ T cells leads to death by retrovirally induced erythroleukemia (24).At this stage, an important issue is the clarification of whether the anti-FrCasE protective immunity seen in 667 MAb-treated mice is due to actual immunomodulation by the MAb owing to its effector function(s) and/or is the consequence of viral propagation blunting, which would prevent the immune system from being overwhelmed by an excess of antigen and, hence, would give it time to react optimally. To address these two nonexclusive possibilities, we compared here viral propagations, health statuses, and endogenous immune responses in four groups of mice. The first three groups were mice neonatally infected under standard conditions (5 × 104 infectious particles) and treated with either the natural 667 MAb, the antibody effector function-lacking F(ab′)2 fragment of 667, or a neutralizing IgM (672) with effector functions inherently different from those of 667. The last group consisted of mice neonatally infected with a low FrCasE inoculum but not subjected to immunotherapy, which is a condition permitting early viral propagation kinetics similar to those of animals infected and 667 MAb treated under standard conditions. Taken together, our data indicate that the drastic reduction of viral propagation shortly after infection is not sufficient for the induction of protective adaptive immunity and, thereby, point to an immunomodulatory action of 667. Interestingly, they also point to two sequential actions of the administered MAb. In the immediate postinfection period, viral spread is controlled exclusively by 667 neutralizing activity, and later it involves the cytolysis of infected cells owing to FcγR-binding-dependent mechanisms. Finally, our work shows that not all antibody isotypes are equally efficient at protecting infected mice and favoring the mounting of protective immunity, as 672 IgM immunotherapy-treated animals died of erythroleukemia. 相似文献